Ebola Virus Disease: Arun Malik, Navjot Kaur, Priksha Kaushal, Mehak, Ankita Balu, Sukhjeet Singh and Hariom Yadav

EBOLA VIRUS DISEASE
Arun Malik1, Navjot Kaur1, Priksha Kaushal1, Mehak1, Ankita

Balu1, Sukhjeet Singh1 and Hariom Yadav2
1
Department of Biosciences (Biotechnology), Asian College of
Institution, Patiala, India
2
NIDDK, NIH, Bethesda, MD, USA
Email: yadavhariom@gmail.com
An infectious
Generally fetal disease marked by

 fever
Severe internal bleeding
Spread throughout contacts with

Body fluids by Filovirus (Ebola Virus)
HOST
Unknown
Named because of Ebola River
RIVER
In Sudan and Zaire in 1976
FIRST OUTBREAK
In Sudan
Infected over 284 people
Killing 53% of victim
Another strain appeared
Infected another 318 people
Mortality rate was 86%
Known as Reston, Virginia
From the Philippines

Virus infected some, but
patients didn’t develop Ebola
virus haemorrhagic fever.

In 1994
When a female ethnologist was performing a
necropsy on dead chimpanzee
Lady infected herself while performing
necropsy
August 26, 2014 in DRC
Pregnant woman from Ikanamogo village
Who butchered a bush animal
Because ill with symptoms of EVD
Reported to private clinic in Isaka village
Died on 11 August
With death meant,
several healthcare workers were
exposed to Ebola virus
Total cases = 24
Death cases = 13
Human to human transmission
has been established
31 more cases of Ebola reported DRC
Increases to 62
Total no. of deaths reported to 35
There have 68 cases of Ebola Virus reported in DCR

Death cases = 41
Outbreak is unrelated to the current outbreak of
Ebola in West Africa
70 cases reported in DRC

Death cases = 42
70 cases
Death cases = 43
Total cases = 8997
Laboratory confirmed cases = 5006
Total deaths = 4993

On the morning, second healthcare worker reported
to hospital
With low grade fever CDC confirmed-

This worker who tested positive last night travelled
by air on October 13
Nigeria
Senegal
Liberia
Guinea
Sierra Leone
Spain
USA
Transmission of
Ebola virus
Types of Body Fluids That involves in transmission of Ebola virus
BODY FLUIDS
CONTAMINATED OBJECTS THROUGH
WHICH EBOLA VIRUS TRANSMITS
TRADITIONAL
AFRICAN RITUALS
PLAYED ROLE IN
TRANSMISSION OF
VIRUS
OTHER WAYES IN WHICH EBOLA
VIRUS CAN TRANSMIT
MASS CREMATION HAVE BEEN SANCTIONED
BY THE GOVERNMENT IN LIBERIA IN BID TO
HELP TO HALT THE DEADLY VIRUS
THESE SHOCKING PICTURES SHOW THE
BODIES OF EBOLA VICTIMS BEING
BURNED ON HUGE FUNERAL PYRE
FRUIT BATS ARE MAJOR CAUSE FOR THE
TRANSMISSION OF THE EBOLA VIRUS
DISEASE
UNHYGIENIC ENVIRONMENT MAY ALSO BE A
CAUSE OF TRANSMISSION OF EBOLA VIRUS IN
WEST AFRICA
CDC WORKER INCINERATES
MEDICAL WASTE FROM EBOLA
PATIENTS IN ZAIRE
Early signs and symptoms of infections
(7-9 Days)
 FEVER
If there is no
fever there is
no Ebola.
HEADACHE
Severe headaches start developing
NAUSEA
Sickness in the
stomach
and
involuntarily
impulse
to vomit is felt
by patient.
MUSCULAR
PAIN
Joint and
muscle pain
leads to
intense
weakness
throughout
the body of
the person.
TIREDNESS
Day 10th followed by:
Vomiting
An another major
symptom to
approve the person
is infected
by Ebola virus.
Diarrhea
Rashes
Condition worsens on day 11th
BRAIN DAMAGE
Loss of
consciousness ,
Seizures,
Massive internal
bleeding
leads to brain
damage.
Internal & External Bleeding
Bleeding from body
Openings (nose, gums ,gastrointestinal
tract, etc) may be seen
In some patients.
How it is diagnosed?
Diagnosis before testing is completed for
Ebola, test for following disease must be
completed
 Malaria
 Typhoid fever
 Shigellosis
 Cholera
 Leptospirosis
 Rickettsiosis
 Relapsing fever
 Meningitis
 Hepatitis
 Other viral hemorrhagic fevers
It is difficult to distinguish EVD from other infectious
diseases but it can be investigated by some methods
 Antibody-capture enzyme-linked immunosorbent
assay (ELISA)
 Antigen-capture detection tests
 Serum neutralization test
 Reverse transcriptase polymerase chain reaction
(RT-PCR) assay
 Electron microscopy
 Virus isolation by cell culture
Diagnostic Considerations
Although there is no
approved specific
therapy for Ebola virus.
Clinical Findings - include fever of greater than 36.8 C (101.5 F) and
additional signs or symptoms like severe headache, muscle pain, vomiting,
diarrhea, abdominal pain
Risk factors
Those who have had contact with blood, body fluids or human remains of
a patient known to have or suspected to have Ebola virus disease.
Residence in or travel to an area where Ebola virus transmission is active.
Direct handling of bats, rodents or primates from endemic areas.

A high risk exposure includes any of the
following
Percutaneous or mucous membrane exposure to blood
or body fluids of a person with Ebola virus disease.
Direct skin contact with patient having Ebola virus
disease without appropriate personal protective
equipment.
Direct contact with dead body without personal safety
equipments in a country where an Ebola virus disease
outbreak is occurring.
Diagnostic Tests
Rapid blood tests for Marburg and Ebola virus
infection are the most commonly used tests for
diagnosis.
Testing for Ebola and Marburg virus should only be

performed in specialized laboratories.
ELISA
 Rapid blood tests detect specific RNA sequences by
reverse-transcription polymerase chain reaction (RT-PCR)
or viral antigens by enzyme –linked immunosorbent assay
(ELISA).
 Most acute infections are determined through the use of

polymerase chain reaction testing (PCR).
 Virus is generally detectable by RT-PCR between 3 to 10

days after the onset of symptoms.
Other Tests
Antigen detection may be used as a confirmatory test for
immediate diagnosis.
For individuals, who are recovering from Ebola virus

disease, PCR testing is also used to determine when a
patient can be discharged from hospital setting.
In some cases, testing for IgM or IgG antibodies to Ebola

virus may also be useful to monitor the immune response
over time and/or evaluate for past infection.
Stages of symptoms of Ebola virus
 Stage 1
Headache, sore throat, fever, muscle soreness
 Stage 2
High fever, Vomiting, Passive Behaviour
 Stage 3
Bruising, Bleeding from nose, mouth, eyes;
Blood in stool, Impaired liver function
 Stage 4
Loss of consciousness, Seizures, Internal bleeding
leading to death
Hospital Protocol for Ebola hit
 Handling Personal Protective Equipment (PPE)
 Removal
 Isolation
 Fluid Control
 Disinfecting
 No Needles
A new drug target for Ebola virus
Researchers have recently developed a new drug
target in the Ebola virus that could be used against it
to fight the disease
University of Utah chemists have produced a

molecule known as peptide mimic that displays a
functionally critical region of the virus that is
universally conserved in all known species of Ebola
 Coffee, Fermented Soy, homeopathic Spider Venom, And
Vitamin C, May All Hold Promise As Anti Ebola Virus
Therapies.
An Ebola Treatment Centre
Entry point
Ebola infection enters there
to be examined by medical
staff in protective gear
Patients are into two
groups based on the
probability
Low probability ward
Patients could face a long wait
until their test results from the
lab come back, revealing
whether or not they are infected .
Patients who might not have the
deadly virus are isolated from
those suffering from Ebola ,
reducing their exposure to the
infection while In the treatment
centre.
High Probability Ward
Patients suspected of having Ebola based on the initial medical
examination remain here until official confirmation arrives that they
have the virus . Only once the Ebola diagnosis is confirmed they
transferred to another ward
Decontamination
The Utah scientists designed peptide mimic of a

highly conserved region in the Ebola protein that
controls entry of the virus into the human host
cells.
Dressing Room
Dressing for a high risk area is a complex process.
Medicals walk in a pairs , with the partner checking
for any tears in the suit .
The protective equipment includes a surgical cap

and hood ,gogles , medical mask ,impermeable
Mortuary
The mortuary is located outside the clinic but

within the double fence as bodies are highly
infectious .
Patient Exit
 The exit on the side are for patients whose

blood tests show that they do not have ebola ,or
those that recover.
Could Statins Treat Ebola
Statins should be considered as a

possible treatment for Ebola
Statins also have been suggested as a

treatment for patient with sepsis, a
condition that involves an out of control
immune response similar to that seen in
Ebola patients.
Canadian – Made Ebola Vaccine Starting
Clinical Trials In Humans
 Experimental Canadian
made Ebola vaccine is
beginning clinical trials in
healthy humans .
 The results are expected
in December
 Clinical trails are now
starting for an
experimental made in
Canada Ebola vaccine
amid growing global
concern over the disease
that’s left more than
4,000 people dead.
HOW TO PREVENT EVD
If have sudden fever, diarrhoea, or vomiting, go to
the nearest health facility
Make no contact with Ebola affected people
Use a special kind of clothes while treating Ebola

affected people
QUICK ACCESS TO APPROPRIATE
LABORATORY SERVICES

PROPER MANAGEMENT SERVICES
FOR WHO ARE INFECTED
PROPER DISPOSAL OF DEAD
THROUGH CREMATION OR BURIAL
People who go early to the health centre
have a better chance of survival.
CALL 117 WITH YOUR QUESTIONS

Ebola Virus Disease: Arun Malik, Navjot Kaur, Priksha Kaushal, Mehak, Ankita Balu, Sukhjeet Singh and Hariom Yadav

Uploaded by

Copyright:

Available Formats

Ebola Virus Disease: Arun Malik, Navjot Kaur, Priksha Kaushal, Mehak, Ankita Balu, Sukhjeet Singh and Hariom Yadav

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Ebola Virus Disease: Arun Malik, Navjot Kaur, Priksha Kaushal, Mehak, Ankita Balu, Sukhjeet Singh and Hariom Yadav

Uploaded by

Copyright:

Available Formats

EBOLA VIRUS DISEASE

Arun Malik1, Navjot Kaur1, Priksha Kaushal1, Mehak1, Ankita

Generally fetal disease marked by

Spread throughout contacts with

From the Philippines

virus haemorrhagic fever.

There have 68 cases of Ebola Virus reported in DCR

70 cases reported in DRC

Laboratory confirmed cases = 5006

Total deaths = 4993

With low grade fever CDC confirmed-

Residence in or travel to an area where Ebola virus transmission is active.

Direct handling of bats, rodents or primates from endemic areas.

Testing for Ebola and Marburg virus should only be

 Most acute infections are determined through the use of

 Virus is generally detectable by RT-PCR between 3 to 10

For individuals, who are recovering from Ebola virus

In some cases, testing for IgM or IgG antibodies to Ebola

University of Utah chemists have produced a

Vitamin C, May All Hold Promise As Anti Ebola Virus

The Utah scientists designed peptide mimic of a

The protective equipment includes a surgical cap

The mortuary is located outside the clinic but

 The exit on the side are for patients whose

Statins should be considered as a

Statins also have been suggested as a

Make no contact with Ebola affected people

Use a special kind of clothes while treating Ebola

CALL 117 WITH YOUR QUESTIONS

You might also like